Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.311,64
-0,91%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Immatics NV (IMTX) Immatics NV (IMTX) Notizie

Immatics NV

IMTX
10,77
-0,12 (-1,10%)
03 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/3/202412:00GLOBEImmatics Announces Full Year 2023 Financial Results and..
22/1/202418:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/1/202414:58EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/1/202402:30GLOBEImmatics Announces Pricing of $175 Million Public Offering
17/1/202422:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/1/202422:01GLOBEImmatics Announces Proposed Public Offering
16/1/202410:06PRNUSDISCO Pharmaceuticals launches as the surfaceome company..
16/1/202409:59PRNUSDISCO Pharmaceuticals launches as the surfaceome company..
30/11/202310:00GLOBELevicept Appoints Eliot Forster as CEO
14/11/202313:00GLOBEImmatics Announces Third Quarter 2023 Financial Results and..
08/11/202313:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/11/202313:00GLOBEImmatics Reports Interim Clinical Data from ACTengine®..
24/10/202313:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202313:00GLOBEImmatics Receives FDA Regenerative Medicine Advanced Therapy..
14/9/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
13/9/202323:03EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/9/202313:00GLOBEModerna and Immatics Announce Strategic Multi-Platform..
11/9/202312:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/8/202322:11EDGAR2Form F-3 - Registration statement by foreign private issuers
17/8/202313:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/8/202313:00GLOBEImmatics Announces Second Quarter 2023 Financial Results and..
10/8/202313:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/8/202313:00GLOBEImmatics Initiates Phase 1/2 Clinical Trial to Evaluate..
24/7/202313:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/7/202313:00GLOBEImmatics Announces $35 Million Equity Investment from..
16/5/202313:00GLOBEImmatics Announces First Quarter 2023 Financial Results and..
Apertura: 11,08 Min: 10,74 Max: 11,18
Chiusura: 10,89

La tua Cronologia

NASDAQ
IMTX
Immatics NV
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network